Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 3/20 | 0.54 |
| ▸ | CYP2C19 | P33261 | 3/20 | 0.54 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.54 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.54 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.54 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.54 |
| ▸ | SLC1A1 | P43005 | 1/20 | 0.54 |
| ▸ | TSHR | P16473 | 3/20 | 0.52 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | SLC6A1 | P30531 | 2/20 | 0.52 |
| ▸ | SLC6A11 | P48066 | 1/20 | 0.52 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.52 |
| ▸ | SLC6A13 | Q9NSD5 | 1/20 | 0.52 |
| ▸ | PMP22 | Q01453 | 2/20 | 0.48 |
| ▸ | GABRP | O00591 | 2/20 | 0.48 |
| ▸ | GABRD | O14764 | 2/20 | 0.48 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.48 |
| ▸ | GABRG2 | P18507 | 2/20 | 0.48 |
| ▸ | GABRB3 | P28472 | 2/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8256069 | 1.00 | CYP2D6 (0.54) | CYP2D6CYP2C19CYP1A2ALOX15SLC1A3 | |
| SCHEMBL17743413 | 0.97 | CYP2D6 (0.52) | CYP2D6CYP2C19CYP1A2ALOX15SLC1A3 | |
| SCHEMBL8089095 | 0.88 | CYP2D6 (0.47) | CYP2D6CYP2C19CYP1A2ALOX15SLC1A3 | |
| SCHEMBL42967 | 0.88 | — | — | |
| Ammonia Solution, Strong SCHEMBL1014829 | 0.85 | — | — | |
| SCHEMBL17743430 | 0.85 | — | — | |
| Hydrochloric Acid SCHEMBL563782 | 0.85 | — | — | |
| Water SCHEMBL10853319 | 0.85 | — | — | |
| Fluoride SCHEMBL28171923 | 0.85 | — | — | |
| SCHEMBL1248549 | 0.85 | CYP2D6 (0.46) | CYP2D6CYP2C19CYP1A2ALOX15SLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 101 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12098299-B2 | Chemical mechanical polishing slurry and use thereof | ANJI MICROELECTRONICS (SHANGHAI) CO., LTD. (CN) | 2024-09-24 | — | — | US | claimed |
| CN-118256150-A | Chemical mechanical polishing solution | 安集微电子科技（上海）股份有限公司 | 2024-06-28 | — | — | CN | claimed |
| US-11898063-B2 | Chemical-mechanical polishing solution | ANJI MICROELECTRONICS (SHANGHAI) CO., LTD. (CN) | 2024-02-13 | — | — | US | claimed |
| CN-111378379-B | Chemical mechanical polishing solution and application thereof | 安集微电子（上海）有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-111378380-B | Chemical mechanical polishing solution and application thereof | 安集微电子（上海）有限公司 | 2022-05-13 | — | — | CN | claimed |
| US-20220056308-A1 | CHEMICAL MECHANICAL POLISHING SLURRY AND USE THEREOF | ANJI MICROELECTRONICS (SHANGHAI) CO., LTD (CN) | 2022-02-24 | — | — | US | claimed |
| CN-109971359-B | Chemical mechanical polishing solution | 安集微电子（上海）有限公司 | 2021-12-07 | — | — | CN | claimed |
| US-11111413-B2 | Chemical-mechanical polishing solution having high silicon nitride selectivity | ANJI MICROELECTRONICS TECHNOLOGY (SHANGHAI) CO., LTD. (CN) | 2021-09-07 | — | — | US | claimed |
| US-20210163786-A1 | CHEMICAL-MECHANICAL POLISHING SOLUTION | ORFAN BIOTECH SL (ES) | 2021-06-03 | — | — | US | claimed |
| CN-111378377-A | Chemical mechanical polishing solution and application thereof | 安集微电子（上海）有限公司 | 2020-07-07 | — | — | CN | claimed |
| US-20180222863-A1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | ARCTURUS THERAPEUTICS, INC. | 2018-08-09 | — | — | US | claimed |
| US-8968711-B2 | Cosmetic or dermatological composition comprising a polymer bearing junction groups, and cosmetic treatment process | L'OREAL (FR) | 2015-03-03 | — | — | US | claimed |
| CN-102548640-B | Carbon dioxide absorbing liquid | TOSHIBA KK | 2015-02-18 | — | — | CN | claimed |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | L'OREAL (FR) | 2010-10-28 | — | — | US | claimed |
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | L'OREAL (FR) | 2010-09-23 | — | — | US | claimed |
| CN-1062860-C | triazine containing anionic compounds useful as antiviral agents | AMERICAN CYANAMID CO (US) | 2001-03-07 | — | — | CN | claimed |
| CN-1163890-A | Triazine containing anionic compounds useful as antiviral agents | AMERICAN CYANAMID CO (US) | 1997-11-05 | — | — | CN | claimed |
| EP-0300462-B1 | HETEROCYCLIC PEROXYCARBOXYLIC ACIDS | AUSIMONT S.p.A. (IT) | 1993-09-29 | — | — | EP | claimed |
| US-5071584-A | Storage stable, heat resistant | AUSIMONT S.P.A. (IT) | 1991-12-10 | — | — | US | claimed |
| EP-0300462-A2 | Heterocyclic peroxycarboxylic acids | AUSIMONT S.p.A. (IT) | 1989-01-25 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100239509-A1 | COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A POLYMER BEARING JUNCTION GROUPS, AND COSMETIC TREATMENT PROCESS | CUTA, SUCLG1, KRT18 | CYP2D6 3808/4885CYP2C19 1670/4885CYP1A2 3261/4885 |
| US-20100272660-A1 | COSMETIC OR PHARMACEUTICAL COMPOSITION COMPRISING A POLYCONDENSATE, THE SAID POLYCONDENSATE AND METHOD OF COSMETIC TREATMENT | ACMSD, CUTA, PCCA | CYP2D6 2307/4885CYP2C19 453/4885CYP1A2 1104/4885 |
| US-20180222863-A1 | IONIZABLE CATIONIC LIPID FOR RNA DELIVERY | L3MBTL1, L3MBTL3, RNASEH1 | CYP2D6 4229/4885CYP2C19 4333/4885CYP1A2 4225/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.